Chardan
Daniil Gataulin, Ph.D., serves as a Senior Equity Research Analyst at Chardan since July 2021, having previously held positions as Vice President and Senior Equity Research Associate in the same field. Before joining Chardan, Daniil was a Senior Equity Research Associate at Raymond James from February 2019 to July 2021. Daniil's academic background includes a Doctor of Philosophy in Molecular Genetics and Cell Biology from the University of Chicago, where research focused on characterizing the function of the DNA repair protein RecA. Additionally, Daniil holds a Master's degree in Biology with a concentration in Biotechnology from the Illinois Institute of Technology and a Bachelor of Science in Cell and Molecular Biology from Grand Valley State University.
This person is not in any offices
Chardan
Chardan is an independent global investment bank specializing in SPACs, healthcare, and disruptive innovation spanning all sectors. Our range of services include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, NASDAQ and the NYSE Arca, Inc. Disclaimer: Information posted on this Web site is believed to be reliable at the time of posting; Chardan Capital Markets, LLC and its affiliates cannot, however, guarantee the accuracy or completeness of such information or make any warranties with regard to the results to be obtained from its use. Information on this Web site is not intended to provide financial, legal, accounting or tax advice and should not be relied upon in that regard. Chardan Capital Markets, LLC and its affiliates are not responsible in any manner for direct, indirect, special or consequential damages howsoever caused, arising out of the use of this Web site or any of its content.